Twenty-one patients with metabolic syndrome were given a calorie or protein restriction diet in a randomized clinical trial by researchers.

A drug first developed to treat Alzheimer’s disease and sickle cell disease reduces obesity, fatty liver and improves heart function.

Scientists has identified two types of obesity with physiological and molecular differences that may have lifelong consequences for health.

A study found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease and weight gain.

A novel therapy developed at the University of Alabama at Birmingham ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet.

Drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity, and improves heart function.

The risk of type 2 diabetes (T2D) is more than halved by weekly injections of new obesity drug semaglutide, according to new research.

Scientists identified two distinct types of obesity with physiological and molecular differences that have lifelong consequences for health.

Remission of type 2 diabetes is achieved more effectively and has longer-lasting results with bariatric surgery than through medications.

Dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.

The therapy acts through release of nitric oxide whose most important function in the body is relaxing the inner muscles of blood vessels.

Researchers have found that a drug first developed to treat Alzheimer’s disease reduces obesity and fatty liver and improves heart function.

Weight gain can be prevented and perhaps reversed — even during a pandemic — with the help and support of a person's community.

People with fatty liver disease who also have heart disease or who have had a stroke may have an even higher risk of dementia.

Researchers have found that a drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity.

Research groups around the world are therefore looking for substances that stimulate brown fat and thus increase fat burning.

Subjects exposed to any amount of light while sleeping at night were significantly more likely to be obese, and have high blood pressure.

Researchers identified a molecule in the blood that is produced during exercise and can effectively reduce food intake and obesity.

The study examined the feasibility and acceptability of a 12-week behavioral program for weight loss and improved cardiovascular health.

100 children from Martina Children’s hospital in Stockholm were able to try the digi-physical treatment concept over a period of one year.